207 related articles for article (PubMed ID: 23134009)
21. The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.
Kim HK; Park CJ; Jang S; Cho YU; Park SH; Choi J; Park CS; Huh J; Chung YH; Lee JH
Ann Lab Med; 2015 Jan; 35(1):152-4. PubMed ID: 25553299
[No Abstract] [Full Text] [Related]
22. [Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case].
Zhang F; Liu YH; Zhuang HG; Li L; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):414-5. PubMed ID: 21055162
[No Abstract] [Full Text] [Related]
23. Loss of CD3 and TCRγδ expression in a relapsed hepatosplenic T-cell lymphoma.
Hodkoff A; Bentley P; Xu X
Leuk Lymphoma; 2018 Feb; 59(2):479-481. PubMed ID: 28573906
[No Abstract] [Full Text] [Related]
24. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
25. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
26. Primary mediastinal large B-cell lymphoma.
Ergul SM; Lal A; Afri L; Frei-Lahr D
South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
28. A rare entity among childhood malignant lymphomas (large anaplastic T-cell Ki-1 +).
Ulukutlu L; Hitzig W; Maurer R
Turk J Pediatr; 1992; 34(1):37-41. PubMed ID: 1509528
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation.
Reimer P; Rüdiger T; Müller J; Rose C; Wilhelm M; Weissinger F
Ann Hematol; 2003 May; 82(5):305-9. PubMed ID: 12707721
[TBL] [Abstract][Full Text] [Related]
30. B cell lymphoma-associated hemophagocytic syndrome after PBSCT.
Takahashi T; Kanda Y; Mori M; Saito T; Chiba S; Mitani K; Hirai H; Yazaki Y
Bone Marrow Transplant; 1998 Mar; 21(6):623-5. PubMed ID: 9543068
[TBL] [Abstract][Full Text] [Related]
31. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
[TBL] [Abstract][Full Text] [Related]
32. CHOP plus rituximab--balancing facts and opinion.
Cheson BD
N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
[No Abstract] [Full Text] [Related]
33. Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis.
Liu Z; Medeiros LJ; Young KH
Hematol Oncol; 2017 Mar; 35(1):125-129. PubMed ID: 25921311
[TBL] [Abstract][Full Text] [Related]
34. Rosai Dorfman disease and peripheral T-cell lymphoma: A rare co-occurrence.
Tiwari V; Pareek A; Ghori H; Ahirwar M
J Postgrad Med; 2019; 65(1):62-63. PubMed ID: 30464074
[No Abstract] [Full Text] [Related]
35. [Recent advance in peripheral T-cell lymphoma, not otherwise specified].
Zhan HQ; Li XQ; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):353-6. PubMed ID: 20654164
[No Abstract] [Full Text] [Related]
36. Subcutaneous T-cell lymphoma.
Nguyen NQ
Dermatol Online J; 2003 Oct; 9(4):42. PubMed ID: 14594615
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
[TBL] [Abstract][Full Text] [Related]
38. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
[No Abstract] [Full Text] [Related]
39. Images in haematology. Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy.
Hemmaway C; Mian A; Nagy Z
Br J Haematol; 2010 Jul; 150(2):129. PubMed ID: 20487440
[No Abstract] [Full Text] [Related]
40. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
